Wednesday, February 10, 2010, 2:23am EST - Canadian Markets open in 7 hours and 7 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Nektar Therapeutics (NKTR)

 On Feb 9: 11.71 USD  Up 0.31 (2.72%)  
MORE ON NKTR
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Nektar Therapeutics (NasdaqNM:NKTR) Delayed quote dataEdit
After Hours: 11.71 Down 0.00 (0.04%) as of 4:52pm EST on 02/09/10
Last Trade: 11.71 USD
Trade Time: Feb 9
Change: Up 0.31 (2.72%)
Prev Close: 11.40
Open: 11.53
Bid: 10.83 x 100
Ask: 12.16 x 100
1y Target Est: 13.75
Day's Range: 11.40 - 11.76
52wk Range: 4.00 - 12.28
Volume: 611,817
Avg Vol (3m): 726,540
Market Cap: 1.09B
P/E (ttm): N/A
EPS (ttm): -0.20
Div & Yield: N/A (N/A%)
Nektar Therapeutics (NKTR)
1d  5d  3m  6m  1y  2y  5y  max 
Free Annual Reports
 Add NKTR to Portfolio   Download Data

HEADLINES
• Biotech ETFs Immune To Broad Selling
Investor's Business Daily (Mon, Feb 8)
• NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure
EDGAR Online (Thu, Feb 4)
• NEKTAR THERAPEUTICS Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financia
EDGAR Online (Wed, Feb 3)
• Nektar appoints Greer to board
AP (Tue, Feb 2)
• Nektar adds to board of directors
at bizjournals.com (Tue, Feb 2)
• Nektar Therapeutics Appoints R. Scott Greer to Board of Directors
PRNewswire (Tue, Feb 2)
• Symantec adds former Intuit CEO to board
at bizjournals.com (Mon, Feb 1)
• 3 Stocks Ready to Roar
at Motley Fool (Tue, Jan 26)
• Wall Street's Buy List
at Motley Fool (Tue, Jan 26)
• Earnings Surprises For Diagnostics Companies Creates Good Stock Price Entry Point For New Investors According To Industry Expert
Wall Street Transcript (Mon, Jan 25)
More Headlines for NKTR...
ANALYST
EPS Est (next year) (Dec-09) : -0.98
EPS Est (in 2 years) (Dec-10) : -0.30
Avg Rec (current)*: 1.6
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Nektar Therapeutics, a biopharmaceutical company, develops various drug products and product candidates using its proprietary drug delivery technologies.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices